Calibration of reference thromboplastins and standardisation of the prothrombin time ratio
- PMID: 6879511
Calibration of reference thromboplastins and standardisation of the prothrombin time ratio
Abstract
Thromboplastins vary in their sensitivity to the haemostatic defect induced by oral anticoagulants. To provide a means of standardising prothrombin time tests, the World Health Organization adopted in 1977 a scheme for calibrating thromboplastins in terms of an International Reference Preparation. Unfortunately, the model on which this scheme was based does not always hold. A revised calibration model has therefore been developed and this has been tested in a recent collaborative study. The revised model, which retains fundamentally the same principle for standardising prothrombin time tests, has proved suitable for calibrating thromboplastins of different species and types and, moreover, has certain statistical advantages over its predecessor. In September 1982, the WHO Expert Committee on Biological Standardization adopted the revised model. This paper explains the nature and rationale of this change and considers its practical implications.
Similar articles
-
Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.Thromb Haemost. 1979 Dec 21;42(4):1073-114. Thromb Haemost. 1979. PMID: 542923
-
Results of calibration by the Dutch National Reference Laboratory of the thromboplastins included in the ICTH/ICSH collaborative study of prothrombin time standardization.Thromb Haemost. 1979 Dec 21;42(4):1128-31. Thromb Haemost. 1979. PMID: 542925
-
Standardization of coagulation tests.Southeast Asian J Trop Med Public Health. 1999;30 Suppl 3:79-85. Southeast Asian J Trop Med Public Health. 1999. PMID: 10926265
-
[Prothrombin time and its standardization].Rinsho Byori. 2002 Aug;50(8):779-85. Rinsho Byori. 2002. PMID: 12373814 Review. Japanese.
-
[Control of oral anticoagulation. Current concepts].Rev Invest Clin. 1989 Oct-Dec;41(4):371-4. Rev Invest Clin. 1989. PMID: 2698502 Review. Spanish.
Cited by
-
Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.Sci Rep. 2015 Jul 29;5:12778. doi: 10.1038/srep12778. Sci Rep. 2015. PMID: 26220366 Free PMC article.
-
Outpatient management of oral anticoagulation therapy in patients with nonvalvular atrial fibrillation.Bosn J Basic Med Sci. 2009 Nov;9(4):313-9. doi: 10.17305/bjbms.2009.2787. Bosn J Basic Med Sci. 2009. PMID: 20001998 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.Clin Pharmacokinet. 1986 Nov-Dec;11(6):483-504. doi: 10.2165/00003088-198611060-00005. Clin Pharmacokinet. 1986. PMID: 3542339 Review.
-
Effects of feeding state on anticoagulation in adult goats treated with warfarin.J Artif Organs. 2016 Sep;19(3):301-4. doi: 10.1007/s10047-016-0885-x. Epub 2016 Jan 27. J Artif Organs. 2016. PMID: 26815203
-
The international normalized ratio of prothrombin time in the model for end-stage liver disease score: a reliable measure.Clin Liver Dis. 2009 Feb;13(1):63-66. doi: 10.1016/j.cld.2008.09.001. Clin Liver Dis. 2009. PMID: 19150310 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources